# Elutia Inc. (ELUT)

> Source: Nexqual · https://nexqual.com/ELUT · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Elutia Inc. (ELUT), nexqual.com/ELUT" · informational, not investment advice.

**Price:** USD 0.79 (+7.32% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.74 · day 0.71–0.8 · 52w 0.5–1.39 · market cap $34.9M · NCM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (1 analysts), mean target USD 5 (range 5–5).
- Total return with dividends: 1Y -12.3% vs S&P 500 +18.1%; 5Y -85.5% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.15, revenue estimate $1.0M.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 1 analysts; mean target USD 5 (low 5, high 5).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -12.3% | -85.5% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -12.4% | -32.0% |
| Volatility (annualized) | 73.8% | 91.3% |
| Max drawdown | -47.4% (Nov 2025→Dec 2025) | -93.3% (Oct 2022→Dec 2025) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/ELUT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt